Recent Finacing
Recent Raise
Destiny Pharma, based in Brighton, develops antimicrobial candidates via its XF Drug platform, advancing XF-73 nasal gel through clinical trials to prevent post-surgical Staphylococcal infections and pursue licensing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors